Narayana Health has reported robust growth for the quarter and financial year ended March 31, 2026. The company achieved consolidated operating revenues of ₹78,960 million for FY26, representing a 44.0% year-on-year increase. Strong operational performance was driven by a significant rise in cardiac surgeries and improved margins, with FY26 consolidated EBITDA reaching ₹17,169 million at a margin of 21.7%, underscoring the company’s sustained expansion and operational efficiency.
Annual Financial Highlights
Narayana Health demonstrated significant growth throughout FY26. The group reported consolidated operating revenues of ₹78,960 million, marking a substantial 44.0% increase compared to the previous year. The consolidated EBITDA for the year stood at ₹17,169 million, achieving a healthy margin of 21.7%. Furthermore, the company reported a consolidated Profit After Tax (PAT) of ₹8,105 million for FY26, reflecting a margin of 10.3%.
Q4 Performance
For the quarter ended March 31, 2026, the company maintained its momentum with consolidated operating revenues of ₹25,938 million, a 75.8% year-on-year increase and a 20.6% increase quarter-on-quarter. The quarterly EBITDA was recorded at ₹5,392 million with a margin of 20.8%, while the quarterly PAT reached ₹2,280 million at an 8.8% margin.
Clinical and Operational Milestones
Operational excellence remained a core focus, with the group performing over 750 robotic cardiac surgeries during FY26. The Narayana Institute of Cardiac Sciences in Bangalore specifically contributed to this success with 727 robotic cardiac surgeries throughout the year. Additionally, the facility saw a 20% year-on-year growth in TAVI procedures. Infrastructure enhancements were also notable, including the inauguration of next-generation Elekta Radiation Therapy services at Narayana Hospital, Mysuru.
Strategic Outlook and Capital Investment
Narayana Health continues to focus on strengthening its regional footprint through a disciplined capital expenditure strategy. The company has several Greenfield and Lease-based expansion projects underway in Bangalore, Kolkata, and Raipur, with multiple projects expected to reach completion between FY27 and FY29. As of March 31, 2026, the company maintains a solid balance sheet with a net debt-to-equity ratio of 0.49.
Source: BSE
